U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Friday it would require Impax Laboratories Inc and privately held Amneal Pharmaceuticals LLC to divest rights to 10 generic medications as a condition of their merger.
from Reuters: Health News https://reut.rs/2KndamW
http://bit.ly/2zwRqiM